FDA Panel Votes to Enforce Strict New Limitations on Low-T Drugs
In September 2014, an advisory panel with the U.S. Food and Drug Administration (FDA) voted to impose strict new limitations on testosterone drugs. More than 2.3 million men are taking testosterone...
View ArticleMen Taking a Stand with AndroGel Lawsuits
The U.S. Food and Drug Administration (FDA) announced on March 3, 2015 it will require manufacturers to update the warning labels of testosterone drugs to include heart attack and stroke risks. The...
View ArticleFDA Warning Sparks Axiron Lawsuits
On March 3, 2015 the U.S. Food and Drug Administration (FDA) announced that warning labels on testosterone drugs, including Axiron, must include heart attack and stroke risks. The warning came too late...
View Article
More Pages to Explore .....